NCT05891899View on ClinicalTrials.gov

Belgian Antithrombin Deficiency Registry

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2060

Conditions
Antithrombin III Deficiency
Interventions
OTHER

observation

No interventions planned: treatment of patients at the discretion of the treating/responsible physician

Trial Locations (1)

1090

UZ Brussel, Brussels

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER

NCT05891899 - Belgian Antithrombin Deficiency Registry | Biotech Hunter | Biotech Hunter